Related Experiment Video
Updated: May 14, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
A potential role for miRNAs in topical drug development
Joshua W Hagen1, William R Levis
1Department of Medicine, New York Downtown Hospital, New York, NY , USA.
Journal of Drugs in Dermatology : JDD
|February 5, 2013
Summary
MicroRNAs (miRNAs) regulate human physiology and pathology. Exploring miRNA pathways in skin diseases and drug treatments, like diphenylcyclopropenone (DPCP), offers new therapeutic strategies for skin conditions.
Area of Science:
- Dermatology
- Molecular Biology
- RNA Therapeutics
Background:
- MicroRNAs (miRNAs) are small, noncoding RNAs regulating human physiological and pathological processes.
- Emerging research highlights the significant role of miRNAs in dermatologic disorders.
- Advances in small RNA therapeutics offer potential for treating skin diseases by targeting miRNA pathways.
Purpose of the Study:
- To explore the role of miRNA pathways in specific skin diseases.
- To investigate the impact of drug treatments on miRNA pathways.
- To identify novel therapeutic strategies for skin diseases by leveraging miRNA modulation.
Main Methods:
- Review of current literature on miRNA functions in dermatology.
- Analysis of miRNA involvement in various skin conditions.
- Examination of how drugs like diphenylcyclopropenone (DPCP) affect miRNA pathways.
Main Results:
- MiRNAs are critical regulators in both normal skin physiology and various dermatologic pathologies.
- Specific miRNAs are implicated in the pathogenesis of conditions such as skin cancers and alopecia areata.
- Drug treatments, including topical immunomodulators like DPCP, can modulate miRNA expression and activity.
Conclusions:
- Understanding miRNA pathways is crucial for developing advanced dermatologic therapies.
- Targeting miRNA pathways presents a promising strategy for enhancing the efficacy of existing treatments and creating novel therapeutic approaches for skin diseases.
- Further research into miRNA-drug interactions can lead to improved treatments for a range of skin disorders.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...